Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 17,773-17,784 of 23,847
Drug study icon
CompletedNCT01654250

NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

This study exists to understand whether this type of care is both safe enough and useful enough to take further. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Little Rock
ADHDDrugA study involving a medication or substance.From 6 Years to 12 Years
Countries
United States
Sponsor
Pfizer
Condition
ADHD
Behavioral study icon
CompletedNCT06087185

Obesity and Mindful Eating in people with Anxiety

This summary needs review. Please check the official study record and contact the research team for details.

In Porto Alegre
AnxietyBehavioralFrom 18 Years to 50 Years
Countries
Brazil
Sponsor
Hospital de Clinicas de Porto Alegre
Condition
Anxiety
Behavioral study icon
CompletedNCT02529397

Obesity Treatment Enhanced With Working Memory Training

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Burlington
ADHDBehavioralOver 18 Years
Countries
United States
Sponsor
University of Vermont
Condition
ADHD
Drug study icon
Enrolling By InvitationNCT06011460

Observation of Clozapine Treatment Safety in Bipolarity.

This observational study is following people with bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Gdansk
BipolarityDrugFrom 18 Years to 65 Years
Countries
Poland
Sponsor
Medical University of Gdansk
Condition
Bipolarity
Other study type icon
CompletedNCT01770704

Observation Study of the Clinical Management of Bipolarity

This study exists to learn from real-world information that can show how this type of care fits into care. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

Multiple locations, including Beijing
BipolarityOtherOver 18 Years
Countries
China
Sponsor
AstraZeneca
Condition
Bipolarity
Drug study icon
CompletedNCT01734278

Observational Post-Authorisation Safety Study of Asenapine (Sycrest)

This study exists to learn from real-world information that can show how the medication Asenapine fits into care. Researchers are trying to understand how people respond to the medication Asenapine in practice and what may need to be adjusted.

In Stafford
BipolarityOtherOver 18 Years
Countries
United Kingdom
Sponsor
Professor Saad Shakir
Condition
Bipolarity
Drug study icon
SuspendedNCT03513549

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolarity type I

This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

In Raleigh
Bipolarity, SchizophreniaDrugOver 18 Years
Countries
United States
Sponsor
Alexza Pharmaceuticals, Inc.
Condition
Bipolarity, Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.